Vitamin D supplementation compared to placebo in people with First Episode psychosis - Neuroprotection Design (DFEND): a protocol for a randomised, double-blind, placebo-controlled, parallel-group trial

被引：0
|
作者：
Fiona Gaughran
Dominic Stringer
Michael Berk
Shubulade Smith
David Taylor
Eromona Whiskey
Sabine Landau
Robin Murray
Philip McGuire
Poonam Gardner-Sood
Gabriella Wojewodka
Simone Ciufolini
Harriet Jordan
Jessie Clarke
Lauren Allen
Amir Krivoy
Brendon Stubbs
Philippa Lowe
Maurice Arbuthnott
Shanaya Rathod
Andrew Boardman
Mudasir Firdosi
John J. McGrath
机构：
[1] King’s College London,Department of Psychosis Studies
[2] Institute of Psychiatry,Department of Biostatistics and Health Informatics
[3] Psychology and Neuroscience,Clinical Trials Facility, Research Department, Tom Rudd Unit
[4] South London and Maudsley NHS Foundation Trust,National Centre for Register
[5] King’s College London,Based Research
[6] Institute of Psychiatry,undefined
[7] Psychology and Neuroscience,undefined
[8] Deakin University and Barwon Health,undefined
[9] Carer Expert and Chair of Trustees,undefined
[10] Rethink Mental Illness,undefined
[11] Moorgreen Hospital,undefined
[12] Cheshire & Wirral Partnership NHS Trust,undefined
[13] Churton House,undefined
[14] South West London and St George’s Mental Health NHS Trust,undefined
[15] Queen Mary’s Hospital,undefined
[16] Queensland Centre for Mental Health Research,undefined
[17] The Park Centre for Mental Health,undefined
[18] Queensland Brain Institute,undefined
[19] University of Queensland,undefined
[20] Aarhus University,undefined
来源：
Trials | / 21卷
关键词：
Psychosis; First episode; Vitamin D; 25OHD; Randomised controlled trial; Positive and Negative Syndrome Scale; Mental health;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Vitamin D supplementation compared to placebo in people with First Episode psychosis-Neuroprotection Design (DFEND): a protocol for a randomised, double-blind, placebo-controlled, parallel-group trial
    Gaughran, Fiona
    Stringer, Dominic
    Berk, Michael
    Smith, Shubulade
    Taylor, David
    Whiskey, Eromona
    Landau, Sabine
    Murray, Robin
    McGuire, Philip
    Gardner-Sood, Poonam
    Wojewodka, Gabriella
    Ciufolini, Simone
    Jordan, Harriet
    Clarke, Jessie
    Allen, Lauren
    Krivoy, Amir
    Stubbs, Brendon
    Lowe, Philippa
    Arbuthnott, Maurice
    Rathod, Shanaya
    Boardman, Andrew
    Firdosi, Mudasir
    McGrath, John J.
    [J]. TRIALS, 2020, 21 (01)
  • [2] Lamotrigine for neuroprotection in secondary progressive multiple sclerosis: a randomised, double-blind, placebo-controlled, parallel-group trial
    Kapoor, Raju
    Furby, Julian
    Hayton, Thomas
    Smith, Kenneth J.
    Altmann, Daniel R.
    Brenner, Robert
    Chataway, Jeremy
    Hughes, Richard A. C.
    Miller, David H.
    [J]. LANCET NEUROLOGY, 2010, 9 (07): : 681 - 688
  • [3] Tadalafil in patients with chronic obstructive pulmonary disease: a randomised, double-blind, parallel-group, placebo-controlled trial
    Goudie, Andrew R.
    Lipworth, Brian J.
    Hopkinson, Pippa J.
    Wei, Li
    Struthers, Allan D.
    [J]. LANCET RESPIRATORY MEDICINE, 2014, 2 (04): : 293 - 300
  • [4] Vitamin D supplementation for primary dysmenorrhea: a double-blind, randomized, placebo-controlled trial
    Rahnemaei, Fatemeh Alsadat
    Gholamrezaei, Ali
    Afrakhteh, Maryam
    Zayeri, Farid
    Vafa, Mohammad Reza
    Rashidi, Arian
    Ozgoli, Giti
    [J]. OBSTETRICS & GYNECOLOGY SCIENCE, 2021, 64 (04) : 353 - 363
  • [5] Randomized, double-blind, placebo-controlled trial of vitamin D supplementation in Parkinson disease
    Suzuki, Masahiko
    Yoshioka, Masayuki
    Hashimoto, Masaya
    Murakami, Maiko
    Noya, Miki
    Takahashi, Daisuke
    Urashima, Mitsuyoshi
    [J]. AMERICAN JOURNAL OF CLINICAL NUTRITION, 2013, 97 (05): : 1004 - 1013
  • [6] Vitamin D supplementation in subjects with hypovitaminosis D: a randomized double-blind, placebo-controlled trial
    Nugroho, Heri
    Tjokorda, G. D. P.
    Suhartono, Tony
    Darmono
    [J]. BALI MEDICAL JOURNAL, 2021, 10 (01) : 405 - 411
  • [7] Varenicline and counseling for vaping cessation: a double-blind, randomized, parallel-group, placebo-controlled trial
    Pasquale Caponnetto
    Davide Campagna
    Jasjit S. Ahluwalia
    Christopher Russell
    Marilena Maglia
    Paolo Marco Riela
    Carmelo Fabio Longo
    Barbara Busa
    Riccardo Polosa
    [J]. BMC Medicine, 21
  • [8] Varenicline and counseling for vaping cessation: a double-blind, randomized, parallel-group, placebo-controlled trial
    Caponnetto, Pasquale
    Campagna, Davide
    Ahluwalia, Jasjit S.
    Russell, Christopher
    Maglia, Marilena
    Riela, Paolo Marco
    Longo, Carmelo Fabio
    Busa, Barbara
    Polosa, Riccardo
    [J]. BMC MEDICINE, 2023, 21 (01)
  • [9] Letter: budesonide for functional dyspepsia with duodenal eosinophilia-randomised, double-blind, placebo-controlled parallel-group trial
    Talley, N. J.
    Walker, M. M.
    Jones, M.
    Keely, S.
    Koloski, N.
    Cameron, R.
    Fairlie, T.
    Burns, G.
    Shah, A.
    Hansen, T.
    Harris, G.
    Holtmann, G.
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2021, 53 (12) : 1332 - 1333
  • [10] Omega-3 supplementation in young offenders: a randomized, stratified, double-blind, placebo-controlled, parallel-group trial
    Raine, Adrian
    Leung, Chi-Ching
    Singh, Melvinder
    Kaur, Jasmin
    [J]. JOURNAL OF EXPERIMENTAL CRIMINOLOGY, 2020, 16 (03) : 389 - 405
12345